Literature DB >> 20856172

Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration.

Howard F Fine1, Reza Iranmanesh, Lucian V Del Priore, Gaetano R Barile, Louis K Chang, Stanley Chang, William M Schiff.   

Abstract

PURPOSE: Massive subretinal hemorrhage (SRH), defined as a thick submacular bleed that extends past the equator in at least two quadrants, is a rare sequela of age-related macular degeneration. This report describes outcomes after surgical intervention for massive SRH.
METHODS: The study design is a retrospective interventional case series. Records of consecutive patients who underwent surgical intervention for massive SRH were reviewed. Outcomes included change from baseline in postoperative acuity at Months 1, 3, 6, 9, and 12 and postoperative complications.
RESULTS: Fifteen consecutive eyes of 13 patients who underwent surgery for massive SRH were included. Procedures performed on initial surgery included subretinal instillation of 25 μg/0.1 mL tissue plasminogen activator (15 of 15), gas tamponade (12 of 15), oil tamponade (3 of 15), 180° or greater retinotomy (4 of 15), and/or cataract extraction (2 of 15). Patients were followed for a median of 20 months (range, 3-66 months). The median visual acuity at baseline and postoperative Month 1 was hand motions but improved to counting fingers at postoperative Months 3 (P = 0.04), 6 (P = 0.04), 9 (P = 0.04), and 12 (P = 0.10). Of the 15 eyes, 9 required at least 1 additional procedure for an indication of hyphema and/or vitreous hemorrhage (n = 6), retinal detachment (n = 2), glaucoma (n = 1), cataract (n = 1), and aphakia (n = 1). At the time of the onset of SRH, 5 of 13 patients were anticoagulated with warfarin (4 patients) or clopidogrel (1 patient), and 1 was diagnosed with a coagulopathy, factor XI deficiency.
CONCLUSION: Massive SRH related to age-related macular degeneration has a grave prognosis. Risk factors may include anticoagulation and coagulopathy. Limitations of the study include its retrospective nature, small sample size, imprecision in acuity measurements below 20/400, and lack of a control group. In this series, surgical intervention was associated with a modest improvement in median visual acuity up to 1 year postoperatively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20856172     DOI: 10.1097/IAE.0b013e3181e2263c

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  14 in total

1.  Natural evolution and surgical outcome of massive subretinal haemorrhage in a patient with neovascular age-related macular degeneration on warfarin therapy.

Authors:  Zhe Liu; Chuan-Bin Sun; Chao-Yang Hong; Miao-Qin Wu; Ke Yao
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

2.  Visual prognosis of eyes with submacular hemorrhage associated with exudative age-related macular degeneration.

Authors:  Naoko Ueda-Arakawa; Akitaka Tsujikawa; Kenji Yamashiro; Sotaro Ooto; Hiroshi Tamura; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2012-10-04       Impact factor: 2.447

3.  Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy: effectiveness and safety of subretinal tissue plasminogen activator.

Authors:  Shuhei Kimura; Yuki Morizane; Ryo Matoba; Mio Hosokawa; Yusuke Shiode; Masayuki Hirano; Shinichiro Doi; Shinji Toshima; Kosuke Takahashi; Mika Hosogi; Atsushi Fujiwara; Fumio Shiraga
Journal:  Jpn J Ophthalmol       Date:  2017-08-23       Impact factor: 2.447

4.  Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal choroidal vasculopathy.

Authors:  Zhi-Xi Li; Yi-Jun Hu; Alp Atik; Lin Lu; Jie Hu
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

5.  Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy.

Authors:  Chui Ming Gemmy Cheung; Mayuri Bhargava; Li Xiang; Ranjana Mathur; Chan Choi Mun; Doric Wong; Tien Yin Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-26       Impact factor: 3.117

6.  Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy.

Authors:  Shuhei Kimura; Yuki Morizane; Mio Morizane Hosokawa; Yusuke Shiode; Shinichiro Doi; Mika Hosogi; Atsushi Fujiwara; Toshio Okanouchi; Yasushi Inoue; Fumio Shiraga
Journal:  Jpn J Ophthalmol       Date:  2019-06-26       Impact factor: 2.447

7.  SPECKLED HYPOAUTOFLUORESCENCE AS A SIGN OF RESOLVED SUBRETINAL HEMORRHAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Authors:  S Amal Hussnain; Rosa Dolz-Marco; Joshua L Dunaief; Christine A Curcio; K Bailey Freund
Journal:  Retina       Date:  2019-10       Impact factor: 4.256

Review 8.  Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).

Authors:  Ursula Schmidt-Erfurth; Victor Chong; Anat Loewenstein; Michael Larsen; Eric Souied; Reinier Schlingemann; Bora Eldem; Jordi Monés; Gisbert Richard; Francesco Bandello
Journal:  Br J Ophthalmol       Date:  2014-09       Impact factor: 4.638

9.  An Innovatory Surgical Technique for Submacular Hemorrhage Displacement by Means of a Bioengineering Perspective.

Authors:  George Pappas; Nectarios Vidakis; Markos Petousis; Vasiliki Kounali; Apostolos Korlos
Journal:  Vision (Basel)       Date:  2021-05-18

10.  Successful displacement of a traumatic submacular hemorrhage in a 13-year-old boy treated by vitrectomy, subretinal injection of tissue plasminogen activator and intravitreal air tamponade: a case report.

Authors:  Shinichiro Doi; Shuhei Kimura; Yuki Morizane; Yusuke Shiode; Mio Hosokawa; Masayuki Hirano; Mika Hosogi; Atsushi Fujiwara; Kazuhisa Miyamoto; Fumio Shiraga
Journal:  BMC Ophthalmol       Date:  2015-08-07       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.